Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for GNGBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 49.35%
March 31, 2026 44.94%
December 31, 2025 44.15%
September 30, 2025 42.96%
June 30, 2025 44.51%
March 31, 2025 45.58%
December 31, 2024 42.42%
September 30, 2024 41.64%
June 30, 2024 44.05%
March 31, 2024 45.06%
December 31, 2023 40.48%
September 30, 2023 43.88%
June 30, 2023 39.76%
March 31, 2023 45.85%
December 31, 2022 40.68%
September 30, 2022 45.17%
June 30, 2022 43.75%
March 31, 2022 45.66%
December 31, 2021 46.11%
September 30, 2021 45.65%
June 30, 2021 48.26%
March 31, 2021 45.97%
December 31, 2020 43.79%
September 30, 2020 48.21%
June 30, 2020 45.13%
Date Value
March 31, 2020 44.19%
December 31, 2019 44.12%
September 30, 2019 42.16%
June 30, 2019 40.86%
March 31, 2019 41.55%
December 31, 2018 42.53%
September 30, 2018 38.52%
June 30, 2018 42.38%
March 31, 2018 49.38%
December 31, 2017 43.30%
September 30, 2017 44.56%
June 30, 2017 44.40%
March 31, 2017 50.47%
December 31, 2016 45.71%
September 30, 2016 47.27%
June 30, 2016 45.72%
March 31, 2016 47.22%
December 31, 2015 47.24%
September 30, 2015 46.79%
June 30, 2015 46.39%
March 31, 2015 46.81%
December 31, 2014 49.41%
September 30, 2014 48.93%
June 30, 2014 48.73%
March 31, 2014 49.33%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Xvivo Perfusion AB 63.23%
Paxman AB 3.65%
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
Intuitive Surgical, Inc. 67.76%